[Prenatal risk assessment of chromosome abnormalities. A combination of ultrasonography and biochemical test--the most effective method].
Conner
Peter
P
Centrum för fostermedicin, Karolinska Universitetssjukhuset, Stockholm. peter.conner@karolinska.se
Marsk
Anna
A
Kublickas
Marius
M
Almström
Harald
H
Gustafsson
Sven
S
Westgren
Magnus
M
D015415:Biomarkers / Q000097:blood*; D018997:Chorionic Gonadotropin, beta Subunit, Human / Q000097:blood*; D002869:Chromosome Aberrations; D025063:Chromosome Disorders / Q000097:blood / Q000175:diagnosis* / Q000000981:diagnostic imaging; D005260:Female; D006801:Humans; D008423:Maternal Age; D048208:Nuchal Translucency Measurement; D011247:Pregnancy; D011266:Pregnancy-Associated Plasma Protein-A / Q000032:analysis*; D018570:Risk Assessment / Q000379:methods; D016216:Ultrasonography, Prenatal
D015415:Biomarkers; D018997:Chorionic Gonadotropin, beta Subunit, Human; D011266:Pregnancy-Associated Plasma Protein-A